Literature DB >> 1491752

Glutaric aciduria type 1 an atypical presentation together with some observations upon treatment and the possible cause of cerebral damage.

J M Land1, P Goulder, A Johnson, J Hockaday.   

Abstract

This report describes an infant diagnosed aged twenty-five months as having glutaric aciduria Type 1 (GA 1). Initial presentation was with isolated macrocephaly at four months of age. Severe hypertonia, and dystonia, within 24 hours of minor head injury occurred at nineteen months of age. Serial cranial imaging showed subdural fluid collections, and increasing underlying cerebral atrophy, mainly frontal and temporal. Confirmation of the clinical diagnosis required repeated blood and urine analysis by high performance liquid chromatography and gas chromatography/mass spectrometry; diagnosis was later confirmed enzymologically. Treatment with riboflavin, L-carnitine, vigabatrin and baclofen, produced some symptomatic relief; a low protein diet, nitrazepam and sodium valproate appeared of less obvious use. The rationale for these attempts at treatment is discussed. The possible role of quinolinic acid in the genesis of the fronto temporal and striatal atrophy is discussed and measurement of the quinolinate concentration in cerebrospinal fluid (CSF) of this case and age-related controls is presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491752     DOI: 10.1055/s-2008-1071366

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

1.  Glutaric aciduria type I: pathomechanisms of neurodegeneration.

Authors:  K Ullrich; B Flott-Rahmel; P Schluff; U Musshoff; A Das; T Lücke; R Steinfeld; E Christensen; C Jakobs; A Ludolph; A Neu; R Röper
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I.

Authors:  B Flott-Rahmel; C Falter; P Schluff; R Fingerhut; E Christensen; C Jakobs; U Musshoff; J D Fautek; T Deufel; A Ludolph; K Ullrich
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 3.  Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

Authors:  C Mühlhausen; G F Hoffmann; K A Strauss; S Kölker; J G Okun; C R Greenberg; E R Naughten; K Ullrich
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Animal models for glutaryl-CoA dehydrogenase deficiency.

Authors:  D M Koeller; S Sauer; M Wajner; C F de Mello; S I Goodman; M Woontner; C Mühlhausen; J G Okun; S Kölker
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Glutaric aciduria: improved MR appearance after aggressive therapy.

Authors:  C H Cho; A C Mamourian; J Filiano; R E Nordgren
Journal:  Pediatr Radiol       Date:  1995

Review 6.  Subdural hematomas: glutaric aciduria type 1 or abusive head trauma? A systematic review.

Authors:  Marloes E M Vester; Rob A C Bilo; Wouter A Karst; Joost G Daams; Wilma L J M Duijst; Rick R van Rijn
Journal:  Forensic Sci Med Pathol       Date:  2015-07-29       Impact factor: 2.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.